ARCA biopharma

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARCA biopharma and other ETFs, options, and stocks.

About ABIO

ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for cardiovascular diseases. The firm focuses on the cardiovascular pathophysiology, molecular genetics, and clinical development.

CEO

Michael R. Bristow

CEOMichael R. Bristow

Employees

Employees19

Headquarters

Westminster, Colorado

HeadquartersWestminster, Colorado

Founded

1992

Founded1992

Employees

Employees19

ABIO Key Statistics

Market cap

32.13M

Market cap32.13M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

23.50K

Average volume23.50K

High today

$2.36

High today$2.36

Low today

$2.23

Low today$2.23

Open price

$2.23

Open price$2.23

Volume

19.17K

Volume19.17K

52 Week high

$2.70

52 Week high$2.70

52 Week low

$1.76

52 Week low$1.76

ABIO Earnings

-$0.40

-$0.27

-$0.13

$0.00

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 13, Pre-Market

ActualExpected Mar 13, Pre-Market

ARCA biopharma

Why Robinhood?

ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for cardiovascular diseases. The firm focuses on the cardiovascular pathophysiology, molecular genetics, and clinical development. Show more

ABIO Key Statistics

ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for cardiovascular diseases. The firm focuses on the cardiovascular pathophysiology, molecular genetics, and clinical development.